Literature DB >> 21240995

Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards: is this the tool for biobanking cytological samples in the molecular era?

Gilda da Cunha Santos1, Ni Liu, Ming-Sound Tsao, Suzanne Kamel-Reid, Kayu Chin, William R Geddie.   

Abstract

BACKGROUND: The aims of this study were to compare the quality of DNA recovered from fine-needle aspirates (FNAs) stored on Whatman FTA cards with that retrieved from corresponding cell blocks and to determine whether the DNA extracted from the cards is suitable for multiple mutation analyses.
METHODS: FNAs collected from 18 resected lung tumors and cell suspensions from 4 lung cancer cell lines were placed on FTA Indicating Micro Cards and further processed to produce paired formalin-fixed paraffin-embedded (FFPE) cell blocks. Fragment analysis was used for the detection of EGFR exon 19 deletion, and direct sequencing for detection of EGFR exon 21 L858R mutation and exon 2 deletion of KRAS. Corresponding FFPE tissue sections from 2 resection specimens were also tested.
RESULTS: Analyses were successful with all FNAs and lung cancer-derived cell lines collected on cards. Polymerase chain reaction failed in 2 cell blocks. For FNAs collected on cards, 5 cases showed EGFR and 3 showed KRAS mutations. Eleven cases were wild type. With cell blocks, 4 cases were found to harbor KRAS and 4 harbored EGFR mutations. All lung cancer-derived cell lines tested positive for their respective mutations, and there was complete agreement between card and cell block FNA samples for EGFR exon 21. For EGFR exon 19, 1 of 18 cases showed discordant results between the card and cell block, and for KRAS 1 of 17. The two resection specimens tested gave concordant results with the FTA card.
CONCLUSIONS: Storage of cytologic material on FTA cards can maximize and simplify sample procurement for multiple mutational analyses with results similar to those from cell blocks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21240995     DOI: 10.1002/cncy.20102

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  4 in total

1.  Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.

Authors:  Katsuyuki Kiura; Kiyotaka Yoh; Nobuyuki Katakami; Naoyuki Nogami; Kazuo Kasahara; Toshiaki Takahashi; Isamu Okamoto; Mireille Cantarini; Rachel Hodge; Hirohiko Uchida
Journal:  Cancer Sci       Date:  2018-02-27       Impact factor: 6.716

2.  Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™.

Authors:  Malin Berggrund; Daniel Ekman; Inger Gustavsson; Karin Sundfeldt; Matts Olovsson; Stefan Enroth; Ulf Gyllensten
Journal:  J Circ Biomark       Date:  2016-01-01

3.  High throughput sequencing of T-cell receptor repertoire using dry blood spots.

Authors:  Shang-Gin Wu; Wenjing Pan; Hongna Liu; Miranda L Byrne-Steele; Brittany Brown; Mollye Depinet; Xiaohong Hou; Jian Han; Song Li
Journal:  J Transl Med       Date:  2019-02-18       Impact factor: 5.531

4.  Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.

Authors:  Jingwei Shao; Guirong Zheng; Hongning Chen; Jian Liu; Aixiao Xu; Fan Chen; Tao Li; Yusheng Lu; Jianguo Xu; Ning Zheng; Lee Jia
Journal:  Oncotarget       Date:  2017-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.